How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

IAM1363 is a Potent, Selective, and Irreversible HER2 and Pan-HER2 Mutant Small Molecule Inhibitor for HER2-Driven NSCLC

calendar_today September 9, 2025 person domain iambic

Research findings demonstrating IAM1363’s capabilities as a targeted lung cancer therapeutic.

open_in_new Read original post